EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidence of loiasis clinical manifestations in a rural area of the Republic of Congo: Results from a longitudinal prospective study (the MorLo project)

Jérémy T Campillo iD, Biam-Miveck Pakat-Pambou, Bachiratou Sahm, Sébastien D S Pion, Marlhand C Hemilembolo, Elodie Lebredonchel, Michel Boussinesq, François Missamou, Cédric B Chesnais

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0012868 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Jérémy T Campillo und 8 weiteren Autor:innen. Beteiligte Einrichtung: TransVIHMI, Université de Montpellier, INSERM Unité, Institut de Recherche pour le Développement (IRD), Montpellier, France. Hauptthemen laut MEDLINE: Loiasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council (ERC), HORIZON EUROPE European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Loiasis is endemic in Central Africa. Despite evidence of clinical complications and increased mortality, it remains excluded from the list of neglected tropical diseases. The main manifestations are Calabar swellings (CS), Eyeworm (EW) and non-specific general symptoms such arthralgia and pruritus. We calculated incidence rates for clinical manifestations of loiasis from a 13-month study on clinical manifestations in 991 individuals living in Loa loa -endemic areas in the Republic of Congo. Methodology From September 2022 to September 2023, community health workers collected weekly symptoms from cohort participants. Detailed data on symptom duration, intensity, associated pruritus, and impact on sleep were recorded. Laboratory procedures included thick blood smear for L. loa microfilaremia measurement, creatininemia measurement and eosinophilia counts. We used multiple failure analysis and frailty models to calculate incidence rates of EW, CS, arthralgia, pruritus and absence from work (AfW) and to analyses factors associated with increased incidence of each symptom. The population-attributable fractions (PAFs) associated with loiasis were also calculated for pruritus, AfW and arthralgia. Principal findings Among the studied manifestations, arthralgia had the highest incidence rate at 555.2 cases per 1000 Person-Year (PY), followed by pruritus (332.3 cases/1000 PY), AfW (298.6/1000 PY), EW (266.4/1000 PY), and CS (213.8/1000 PY). Notably, the incidence rates of CS, pruritus, arthralgia, and AfW were statistically significantly higher in the subgroup of individuals who experienced at least one episode of EW during the follow-up period. EW occurrence is more frequent when microfilaremia is present. The PAFs of AfW, pruritus and arthralgia, associated with loiasis was 18.0% [07.3–27.6], 20.8% [11.6–29.1] and 12.1% [3.1–20.1], respectively. Conclusion/significance This is the first study to provide incidence rates for the clinical manifestations of loiasis. These estimates are crucial for assessing the burden of loiasis. The findings highlight the disease’s impact on quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LoiasisHumansIncidenceMaleFemaleProspective StudiesAdultLongitudinal StudiesMiddle AgedRural PopulationCongoYoung AdultAdolescentChildPruritusArthralgiaChild, PreschoolLoaAgedAnimals

Autor:innen und Institutionen

  • TransVIHMI, Université de Montpellier, INSERM Unité, Institut de Recherche pour le Développement (IRD), Montpellier, France.
  • Hôpital de référence du district sanitaire de Sibiti, Lékoumou Department, Sibiti, Republic of Congo.
  • Programme National de Lutte contre l'Onchocercose, Direction de l'Épidémiologie et de la Lutte contre la Maladie, Ministère de la Santé et de la Population, Brazzaville, Republic of Congo.
  • Département de Biochimie, Hôpitaux Universitaires Paris Nord Val de Seine - site Bichat, Assistance Publique des Hôpitaux de Paris, Paris, France.

ORCID-Profile: Jérémy T Campillo

Förderung

  • European Research Council (ERC)
  • HORIZON EUROPE European Research Council

Zitieren

APA

Campillo, J. T., Pakat-Pambou, B. M., Sahm, B., Pion, S. D. S., Hemilembolo, M. C., Lebredonchel, E., Boussinesq, M., Missamou, F., & Chesnais, C. B. (2025). Incidence of loiasis clinical manifestations in a rural area of the Republic of Congo: Results from a longitudinal prospective study (the MorLo project). PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012868

Vancouver

Campillo JT, Pakat-Pambou BM, Sahm B, Pion SDS, Hemilembolo MC, Lebredonchel E, et al. Incidence of loiasis clinical manifestations in a rural area of the Republic of Congo: Results from a longitudinal prospective study (the MorLo project). PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012868

BibTeX
@article{Campillo2025,
  author = {Campillo, Jérémy T and Pakat-Pambou, Biam-Miveck and Sahm, Bachiratou and Pion, Sébastien D S and Hemilembolo, Marlhand C and Lebredonchel, Elodie and Boussinesq, Michel and Missamou, François and Chesnais, Cédric B},
  title = {Incidence of loiasis clinical manifestations in a rural area of the Republic of Congo: Results from a longitudinal prospective study (the MorLo project)},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0012868}
}
Kostenlos starten →